Status:
UNKNOWN
The Auxiliary Effects of Fucoidan for Locally Advanced Rectal Cancer Patients
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT
Eligibility:
All Genders
20-80 years
Brief Summary
This is a double-blind, randomized, placebo-controlled, parallel study. The main goal is to investigate the auxiliary effects of Fucoidan for the patients with locally advanced rectal cancer who recei...
Eligibility Criteria
Inclusion
- Age was more/equal to 20 year-old and less/equal to 80 year-old
- Diagnosed as locally advanced rectal cancers by pathological biopsy and image study.
- ECOG performance status within 0 to 2 points
- Excepted life remaining at least 4 months
- Females with fertility are willing to use effective contraception during the period of study
- Willing to follow the test procedures and tracking procedures
- sign the inform consent form
Exclusion
- Suffering from other primary malignant tumors 2.Females who are pregnant, planning to become pregnant, or breastfeeding 3.Participate in other interventional clinical trial within the first 30 days 4.Suffering from major mental illness such as mental retardation and mental disorders 5.Unable to understand and answer research questions (oral or written) 6.Abnormal laboratory data within 14 days before joining the study 7.Evidence that subject has a severe or uncontrolled disease
- \-
Key Trial Info
Start Date :
November 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04342949
Start Date
November 9 2018
End Date
December 31 2021
Last Update
April 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung-Ho Memorial Hospital, Kaohsiung Medical University:
Kaohsiung City, Taiwan, 807